New Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors - KFF Health News

Although nearly 40% of Americans 60 and older are obese, Medicare doesn’t cover weight loss medications. Meanwhile, studies haven’t thoroughly examined new drugs’ impact on older adults.

February/March 2023 by Luckbox Magazine - Issuu

Medicare Dilemma: Weight Loss Drugs for Seniors

Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?

KFF Survey: Consumers Want Insurance to Pay for Weight Loss Drugs

How DTC consumer health product sales can disrupt US healthcare, Jim Eischen posted on the topic

New generation of weight loss medications offer promise — but at a price - CBS News

KFF on X: Compared to peer nations, the U.S. faces significantly higher list prices for several major drugs used for weight loss. In the U.S., Ozempic is over five times as expensive as in Japan, and Wegovy is four times as expensive as in Germany.

Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching? - The Good Men Project